At-Risk Populations (HCV)

IVDU's At Risk for Hepatitis C Even in Low HIV Areas

Published in Hepatitis Weekly, June 17th, 1996

Intravenous drug users are at a significant risk for hepatitis C virus infection, even in areas with low HIV seroprevalence, according to a report from Italy.

In Italy, co-infection with HIV and HCV is high among injection drug users. HIV prevalence among IV drug users varies from between 5 percent to over 50 percent, and HCV prevalence has been estimated to range from 60 to 70 percent.

"Previous studies have suggested that HCV incidence rates may be high in areas with low HIV incidence," researcher Giovanni Rezza and colleagues wrote ("Incidence Rate and Risk Factors for HCV Seroconversion Among Injecting Drug Users in an Area with Low HIV...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1996-06-17)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry